Organon & Co. (OGN) PT Lowered to $32 at Piper Sandler
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts OGN Hot Sheet
Price: $13.86 +0.07%
Rating Summary:
2 Buy, 6 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
2 Buy, 6 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Piper Sandler analyst David Amsellem lowered the price target on Organon & Co. (NYSE: OGN) to $32.00 (from $33.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Camtek (CAMT) PT Lowered to $140 at Stifel
- TETRA Technologies Inc. (TTI) PT Lowered to $11 at Stifel
- Datadog (DDOG) PT Lowered to $260 at BTIG
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
